{
    "nctId": "NCT03252912",
    "briefTitle": "Study in Leptomeningeal Metastases of Breast Cancer",
    "officialTitle": "Cerebrospinal Fluid Biomarkers Value: Exploratory and Prospective Study in Leptomeningeal Metastases of Breast Cancer (LCS Bio Sein)",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 51,
    "primaryOutcomeMeasure": "Sensitivity of the CellSearch\u00ae technique on CSF samples in comparison with the conventional cytology on one to three CSF sample",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Male or female patient \u2265 18 years-old, no age limit;\n2. Histologically confirmed diagnosis of BC;\n3. Hormone receptors and HER2 statuses of the primary tumor available;\n4. Suspected LM based on clinical symptoms or signs, or radiological abnormalities;\n5. Indication of diagnosis lumbar puncture decided by the oncologist in charge of the patient;\n6. Patients must be affiliated to a Social Security System;\n7. Patient information and written informed consent form signed prior to any study specific procedures.\n\nExclusion Criteria:\n\n1. History of other cancer(s) than the BC (except completely resected non-melanoma skin cancer or successfully treated in situ carcinoma).\n2. Hormone receptors and/or HER2 statuses of the primary tumor not available;\n3. Patients with a medical contra-indication to the realization of a lumbar puncture;\n4. Patients with psychological, family, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule;\n5. Patients who are pregnant or breast-feeding.\n6. Legal incapacity or limited legal capacity.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}